Exercise Shows Benefits for Metastatic Colorectal Cancer Patients
The Bennett Cancer Center is proud to be a member of the Dana-Farber/Brigham and Women’s Cancer Care Collaborative, providing our staff and patients access to the latest and most effective, evidence-based best practices and standards in cancer treatment and research.
Questions About Colorectal Cancer?
We’re here to help. Contact our Oncology Nurse Navigator, Katharine Radziewicz, RN, OCN, at 203-276-CARE. Press 2.
Learn more about our colorectal cancer services.
This post originally appeared on the Dana-Farber Cancer Institute Insight blog. Reprinted with permission.
Patients with metastatic colorectal cancer may be able to lower the risk of the disease worsening, and improve their chances of survival, if they engage in moderate daily exercise, according to new research by Dana-Farber investigators.
The results of the research, presented at the American Society of Clinical Oncology’s Gastrointestinal Cancer Symposium, contradict the widespread belief that, because the prognosis for patients with metastatic cancer is often poor, there is little benefit to be gained from exercise, the study authors said.
“Research has consistently shown that increased physical activity can improve outcomes for patients with non-metastatic colorectal cancer,” said the study’s lead author, Brendan Guercio, MD, a medical student studying at Dana-Farber at the time the research was completed and now a medical resident at Brigham and Women’s hospital. “This is the first study to indicate that more exercise may benefit patients with metastatic forms of the disease.”
In the study, 1,231 patients participating in a clinical trial of chemotherapy for metastatic colorectal cancer completed a questionnaire on how many hours a week they engaged in various leisure-time activities, ranging from gardening to more strenuous pursuits such as jogging, hiking, and bicycling. Researchers then tracked respondents’ health for the next three and a half years.
The investigators found that during that period, patients who engaged in moderate physical activity for thirty minutes a day had a 16 percent lower risk of the disease worsening than those who didn’t exercise or exercised less. The 30 minutes a day group also had a 19 percent lower risk of dying from any cause than did the others.
It isn’t yet clear, from a physiological standpoint, how exercise creates this benefit, Guercio said. Laboratory research has found that insulin may affect the biology of colorectal cancer, suggesting that it may be more aggressive in people with high levels of insulin or insulin resistance. Regular exercise can lead to lower insulin levels.
“Patients consistently ask regarding other things to consider in addition to standard treatments, and this is the first prospective data that I am aware of for the role of exercise impacting survival in a metastatic colorectal cancer population,” said Jeffrey Meyerhardt, MD, MPH, clinical director of the Center for Gastrointestinal Oncology at Dana-Farber and senior author of the study.